- Sensus Healthcare (NASDAQ:SRTS) has announced the sale of the first SRT-100 Vision™ system in Asia, to Far Eastern Memorial Hospital in Taiwan.
- The hospital, which has more than 1,000 beds, is one of the largest private hospitals in Taiwan.
- Far Eastern Memorial Hospital also plans to publish research on possible new indications for the SRT-100 Vision, which may be instrumental in the support of label expansion beyond non-melanoma skin cancer and keloids worldwide.
- “We are optimistic this sale will open the door to additional sales of our premium-featured Vision system in the region, including across China.” said Benson Suen, Sensus Healthcare’s Vice President of Internation Sales.
More on Sensus Healthcare